FDA Medical Product Approvals: Hearing Before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, First Session, August 8, 1995 |
What people are saying - Write a review
We haven't found any reviews in the usual places.
Contents
Hearing held on August 8 1995 | 8 |
Statement | 20 |
Letters statements etc submitted for the record | 32 |
Copyright | |
1 other sections not shown
Other editions - View all
Common terms and phrases
agency American patients angioplasty aspirin beneficiaries benefit Cardiologists Chairman CLIA clinical trial Committee Congress coronary arteries Corrections Day costs create defibrillator DENNIS HASTERT device approval device manufacturers drug Europe example FDA approval FDA reform Federal regulation field hearing find fine first GEIER GIL GUTKNECHT going Gutknecht HCFA HCFA’s healthcare HMO’s hospital implanted improve ingredient issue JOE SCARBOROUGH labeling life-threatening look LOUISE MCINTOSH SLAUGHTER masks Mayo Clinic MCINTOSH medical device industry medical innovation medical research medical technologies Medicare Medtronic MICHAEL MURPHY Minnesota Medical Association MURPHY Murray occluded office OSHA overly burdensome overseas pace paperwork Paul Citron perform physicians problem procedures protect the public RANDY TATE record regulatory reimbursement resulted Rochester safe safety Schwartz senior citizens specific staff stent subcommittee testimony tests Thank therapy there’s things United VETTER we’re witnesses